CA2336470A1 - Sels de paroxetine - Google Patents

Sels de paroxetine Download PDF

Info

Publication number
CA2336470A1
CA2336470A1 CA002336470A CA2336470A CA2336470A1 CA 2336470 A1 CA2336470 A1 CA 2336470A1 CA 002336470 A CA002336470 A CA 002336470A CA 2336470 A CA2336470 A CA 2336470A CA 2336470 A1 CA2336470 A1 CA 2336470A1
Authority
CA
Canada
Prior art keywords
acid
carboxylic
phenyl
methyl
benzoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002336470A
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2336470A1 publication Critical patent/CA2336470A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des composés de pipéridine, des procédés de préparation de ces derniers, des compositions pharmaceutiques les contenant et leur utilisation à des fins thérapeutiques.
CA002336470A 1998-07-02 1999-06-30 Sels de paroxetine Abandoned CA2336470A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9814316.7 1998-07-02
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (fr) 1998-07-02 1999-06-30 Sels de paroxetine

Publications (1)

Publication Number Publication Date
CA2336470A1 true CA2336470A1 (fr) 2000-01-13

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336470A Abandoned CA2336470A1 (fr) 1998-07-02 1999-06-30 Sels de paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (fr)
JP (1) JP2002519421A (fr)
KR (1) KR20010053337A (fr)
CN (1) CN1314906A (fr)
AP (1) AP2000002017A0 (fr)
AU (2) AU4903999A (fr)
BG (1) BG105204A (fr)
BR (1) BR9911679A (fr)
CA (1) CA2336470A1 (fr)
CZ (1) CZ20004923A3 (fr)
EA (1) EA200100098A1 (fr)
GB (1) GB9814316D0 (fr)
HU (1) HUP0103712A3 (fr)
ID (1) ID27766A (fr)
IL (1) IL140385A0 (fr)
NO (1) NO20006547L (fr)
PL (1) PL345365A1 (fr)
SK (1) SK20242000A3 (fr)
TR (1) TR200100055T2 (fr)
WO (1) WO2000001692A1 (fr)
ZA (2) ZA992899B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004237438B2 (en) 2003-05-07 2011-01-20 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
CA2519189C (fr) 2003-05-07 2012-07-17 Osteologix A/S Sels de strontium solubles dans l'eau pour le traitement de maladies des cartilages et/ou des os
EP1732575B1 (fr) 2004-02-26 2010-12-29 Osteologix A/S Composes a base de strontium destines a etre utilises dans la prevention ou le traitement de conditions d'os necrotiques
JP4954867B2 (ja) 2004-05-06 2012-06-20 オステオロジックス エイ／エス 有機金属塩類を製造するための高収率で迅速な合成法
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
JP2010504281A (ja) * 2006-07-27 2010-02-12 エミスフェアー・テクノロジーズ・インク アリールスルファニル化合物、および活性薬剤を送達するための組成物
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
CA2206592A1 (fr) * 1996-05-30 1997-11-30 Shu-Zhong Wang Methode de preparation de chlorhydrate de paroxetine amorphe
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
EP1078925A1 (fr) * 1997-06-10 2001-02-28 Synthon B.V. Composés 4-phenylpiperidine
KR20010040711A (ko) * 1998-02-06 2001-05-15 피터 기딩스 파록세틴의 염

Also Published As

Publication number Publication date
CN1314906A (zh) 2001-09-26
JP2002519421A (ja) 2002-07-02
TR200100055T2 (tr) 2001-07-23
KR20010053337A (ko) 2001-06-25
EA200100098A1 (ru) 2001-08-27
WO2000001692A1 (fr) 2000-01-13
NO20006547L (no) 2001-02-12
GB9814316D0 (en) 1998-09-02
ZA200100020B (en) 2002-03-25
NO20006547D0 (no) 2000-12-21
EP1091958A1 (fr) 2001-04-18
BR9911679A (pt) 2002-01-29
BG105204A (en) 2001-11-30
IL140385A0 (en) 2002-02-10
HUP0103712A2 (hu) 2002-05-29
SK20242000A3 (sk) 2001-07-10
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (cs) 2001-08-15
AU4903999A (en) 2000-01-24
PL345365A1 (en) 2001-12-17
HUP0103712A3 (en) 2002-09-30
ZA992899B (en) 2000-03-29
AU2002100370A4 (en) 2002-06-06
ID27766A (id) 2001-04-26

Similar Documents

Publication Publication Date Title
RU2529484C2 (ru) Ациламино-замещенные производные конденсированных циклопентанкарбоновых кислот и их применение в качестве фармацевтических средств
US7446222B2 (en) Phenyl compounds
AU2008241490B2 (en) Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid GPR40 modulators
CA2336470A1 (fr) Sels de paroxetine
EP1278734A2 (fr) Methode de traitement se basant sur l'utilisation de derives de phenyle et de biaryle comme inhibiteurs de prostaglandine e
CZ147797A3 (cs) Substituované 4-biarylmáselné nebo 5-biarylpentanové kyseliny a deriváty jako inhibitory matricové metalloproteasy
HU183085B (en) Process for preparing new phenoxy-alkyl-carboxylic acid derivatives and pharmaceutical compositions containing thereof
JP2002516305A (ja) インスリン抵抗性および高血糖症の治療に有用な２，３，５−置換ビフェニル
JP6310931B2 (ja) Ｇｐｒ１２０アゴニストとしてのチオアリール誘導体
AU776831B2 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
CN101553456B (zh) 脂氧素a4类似物的晶体钾盐
WO2010118241A2 (fr) Inhibiteurs des protéine-tyrosine phosphatases
US6242493B1 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
EP1654247A1 (fr) Alkynylaryl-carboxamides
DE69030202T2 (de) Phenylalkan(en)-Säuren mit Leukotrien B4 antagonistischer Wirkung
US20090192190A1 (en) Benzoic Acid Derivatives that are Modulators or Agonists of GlyR
EP1258473A1 (fr) Derives d'acide benzoique, procede de production desdits derives, et medicament contenant ces derives comme principe actif
US6710205B2 (en) Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
DE69614833T2 (de) Entzündungshemmende benzoesäurederivate
MXPA01000133A (en) Salts of paroxetine
JPH05507698A (ja) ロイコトリエン関連疾患治療用アミド結合ピリジル―安息香酸誘導体
JPH08502278A (ja) 置換されたエタノールアミンエステル
JPS5865263A (ja) Ｎ−アシル化ヒドロキシ−アミノ−アリ−ルスルホン酸の製造方法
WO2012174926A1 (fr) Dérivés d'isopropyldiméthylazulènesulfonamide n-substitués, leur procédé de préparation et utilisation
US2321332A (en) N-(p-amino and acyl-p-aminoarylsulphonylamido)-pyridine-carboxylic acids and thermal decomposition product thereof

Legal Events

Date Code Title Description
FZDE Discontinued